» Authors » Rutger R G Knops

Rutger R G Knops

Explore the profile of Rutger R G Knops including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 81
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Morfouace M, Schoot R, Hol M, Minard-Colin V, Kolb F, Bolle S, et al.
Eur J Endocrinol . 2025 Jan; 192(1):25-33. PMID: 39775705
Objective: Survivors of pediatric head and neck rhabdomyosarcoma (HNRMS) are at risk of developing endocrinopathies following local treatment, resulting from radiation damage to the pituitary gland, hypothalamus, or thyroid gland,...
2.
Gelineau N, van Barneveld A, Samim A, Van Zogchel L, Lak N, Tas M, et al.
Front Oncol . 2023 Sep; 13:1209150. PMID: 37664065
Background And Aims: Solid tumors account for about 30% of all pediatric cancers. The diagnosis is typically based on histological and molecular analysis of a primary tumor biopsy. Liquid biopsies...
3.
de Vries I, Ewijk R, Adriaansen L, Bohte A, Braat A, Davila Fajardo R, et al.
Pediatr Radiol . 2023 Mar; 53(5):1043. PMID: 36930287
No abstract available.
4.
de Vries I, Ewijk R, Adriaansen L, Bohte A, Braat A, Davila Fajardo R, et al.
Pediatr Radiol . 2023 Feb; 53(4):788-812. PMID: 36843091
Rhabdomyosarcoma, although rare, is the most frequent soft tissue sarcoma in children and adolescents. It can present as a mass at nearly any site in the body, with most common...
5.
Diepstraten F, Wiersma J, Schoot R, Knops R, Zuur C, Meijer A, et al.
Cancers (Basel) . 2022 Dec; 14(23). PMID: 36497230
Purpose: The frequency and patterns of HL in a HNRMS survivor cohort were investigated. A dose-effect relationship between the dose to the cochlea and HL was explored. Methods: Dutch survivors...
6.
Meister M, Groot Koerkamp M, de Souza T, Breunis W, Frazer-Mendelewska E, Brok M, et al.
EMBO Mol Med . 2022 Aug; 14(10):e16001. PMID: 35916583
Rhabdomyosarcomas (RMS) are mesenchyme-derived tumors and the most common childhood soft tissue sarcomas. Treatment is intense, with a nevertheless poor prognosis for high-risk patients. Discovery of new therapies would benefit...
7.
Klein K, van Litsenburg R, de Haas V, Dors N, van den Heuvel-Eibrink M, Knops R, et al.
Pediatr Blood Cancer . 2019 Dec; 67(4):e28099. PMID: 31872548
Background: With the current more effective treatment regimens for pediatric acute myeloid leukemia (AML), research on early death (ED), treatment-related mortality (TRM), and toxicity becomes increasingly important. The aim of...
8.
Loeffen E, Knops R, Boerhof J, Feijen E, Merks J, Reedijk A, et al.
Eur J Cancer . 2019 Oct; 121:113-122. PMID: 31569066
Aim: Intensive treatment regimens have contributed to a marked increase in childhood cancer survival rates. Death due to treatment-related adverse effects becomes an increasingly important area to further improve overall...
9.
Knops R, Kremer L, Verhagen A
BMC Palliat Care . 2015 Nov; 14:57. PMID: 26542477
Background: Children dying of a life threatening disease suffer a great deal at the end of life. Symptom control is often unsatisfactory, partly because many caregivers are simply not familiar...